Gout Incidence Down With SGLT2 Inhibitors in Type 2 Diabetes

MONDAY, Jan. 13, 2020 -- Adults with type 2 diabetes newly prescribed a sodium-glucose cotransporter-2 (SGLT2) inhibitor have a lower incidence of gout than those prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news